GlassScriptPhysician profile
Kourosh Kojouri
NPI 1396821807
$4,924.72
in general payments reported to CMS, 2019-2025
14 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.00 · 2021: $4,098 · 2024: $224 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,137.96 | 2020-2021 | |
| Abbvie INC. | $229.33 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $91.95 | 2025 | |
| Janssen Biotech, INC. | $76.90 | 2024-2025 | Tremfya |
| Genzyme Corporation | $61.53 | 2025 | |
| Leo Pharma INC. | $61.49 | 2024 | Adbry |
| Merz North America, INC. | $54.97 | 2024-2025 | |
| Incyte Corporation | $46.27 | 2024-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $45.61 | 2025 | |
| Ucb, INC. | $31.61 | 2024 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $26.91 | 2024 | Libtayo |
| Cipher Pharmaceuticals US LLC | $24.26 | 2025 | Spinosad, Natroba |
| Galderma Laboratories, L.P. | $20.89 | 2025 | Dysport |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.04 | 2024 | Cabtreo, Arazlo, Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kourosh Kojouri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.